Apolipoprotein E in Alzheimer's disease: an update.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Annual Review of Neuroscience

• Publication date

  2014-07-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1146/annurev-neuro-071013-014300PMID 24821312
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory

  2014cited by this paper
• Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study.

  2014cited by this paper
• Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease

  2014cited by this paper
• The Liver X Receptor Agonist GW3965 Improves Recovery from Mild Repetitive Traumatic Brain Injury in Mice Partly through Apolipoprotein E

  2013cited by this paper
• 2013 Alzheimer's disease facts and figures

  2013cited by this paper
• Genetic insights in Alzheimer's disease.

  2013cited by this paper
• Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

  2013cited by this paper
• Levels of Soluble Apolipoprotein E/Amyloid-β (Aβ) Complex Are Reduced and Oligomeric Aβ Increased with APOE4 and Alzheimer Disease in a Transgenic Mouse Model and Human Samples*♦

  2013influential reference
• ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions

  2013cited by this paper
• Response to Comments on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

  2013cited by this paper
• Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease.

  2013cited by this paper
• Variant of TREM2 associated with the risk of Alzheimer's disease.

  2013cited by this paper
• Human apolipoprotein E4 worsens acute axonal pathology but not amyloid-β immunoreactivity after traumatic brain injury in 3xTG-AD mice.

  2013cited by this paper
• The Pro-Neurotrophin Receptor Sortilin Is a Major Neuronal Apolipoprotein E Receptor for Catabolism of Amyloid-β Peptide in the Brain

  2013cited by this paper
• Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

  2013cited by this paper
• Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia

  2013cited by this paper
• APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study

  2013cited by this paper
• Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

  2013cited by this paper
• Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

  2013cited by this paper
• Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

  2013cited by this paper
• Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

  2013cited by this paper
• Blocking the interaction between apolipoprotein E and Aβ reduces intraneuronal accumulation of Aβ and inhibits synaptic degeneration.

  2013influential reference
• Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease

  2013cited by this paper
• TREM2 variants in Alzheimer's disease.

  2013cited by this paper
• APOE-Mimetic Peptides Reduce Behavioral Deficits, Plaques and Tangles in Alzheimer’s Disease Transgenics

  2012cited by this paper
• Altering mitochondrial dysfunction as an approach to treating Alzheimer's disease.

  2012influential reference
• Apolipoprotein E3 (ApoE3) but Not ApoE4 Protects against Synaptic Loss through Increased Expression of Protein Kinase Cϵ

  2012cited by this paper
• APOE genotype alters glial activation and loss of synaptic markers in mice

  2012cited by this paper
• Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent Aβ Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice

  2012influential reference
• Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β.

  2012cited by this paper
• Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.

  2012cited by this paper
• Turning point: Mark Lawrence

  2012cited by this paper
• Apolipoprotein E4 Impairs Macrophage Efferocytosis and Potentiates Apoptosis by Accelerating Endoplasmic Reticulum Stress*

  2012cited by this paper
• The role of inflammatory processes in Alzheimer’s disease

  2012cited by this paper
• Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid β Peptide

  2012cited by this paper
• Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics

  2012cited by this paper
• Low-density Lipoprotein Receptor Represents an Apolipoprotein E-independent Pathway of Aβ Uptake and Degradation by Astrocytes*

  2012cited by this paper
• Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms*♦

  2012cited by this paper
• ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

  2012influential reference
• Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

  2012influential reference
• Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.

  2012cited by this paper
• Amyloid-related imaging abnormalities (ARIA) in Alzheimer’sdisease patients treated with bapineuzumab: A retrospective analysis

  2012cited by this paper
• The Apolipoprotein-E-Mimetic COG112 Protects Amyloid Precursor Protein Intracellular Domain-Overexpressing Animals from Alzheimer's Disease-Like Pathological Features

  2012cited by this paper
• Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease

  2012cited by this paper
• Variant of TREM 2 Associated with the Risk of Alzheimer ’ s Disease

  2012cited by this paper
• A genome-wide scan for common variants affecting the rate of age-related cognitive decline.

  2012cited by this paper
• Apolipoprotein e sets the stage: response to injury triggers neuropathology.

  2012cited by this paper
• Disruption of Arterial Perivascular Drainage of Amyloid-β from the Brains of Mice Expressing the Human APOE ε4 Allele

  2012cited by this paper
• Liver X receptor activation attenuates inflammatory response and protects cholinergic neurons in APP/PS1 transgenic mice.

  2012cited by this paper
• A Multifaceted Role for apoE in the Clearance of Beta-Amyloid across the Blood-Brain Barrier

  2012influential reference
• Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease.

  2012cited by this paper
• APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease*

  2012cited by this paper
• Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis

  2012cited by this paper
• The Isoform-Specific Pathological Effects of ApoE4 in vivo are Prevented by a Fish Oil (DHA) Diet and are Modified by Cholesterol

  2012cited by this paper
• Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer’s disease

  2012influential reference
• Dynamic Analysis of Amyloid β-Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal Aβ during Age-Related Plaque Formation

  2011cited by this paper
• Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance

  2011cited by this paper
• APOE and Alzheimer disease: a major gene with semi-dominant inheritance

  2011influential reference
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages

  2011cited by this paper
• Proteomic analysis of mitochondria in APOE transgenic mice and in response to an ischemic challenge

  2011cited by this paper
• Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease

  2011cited by this paper
• Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis

  2011cited by this paper
• Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

  2011cited by this paper
• Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.

  2011cited by this paper
• Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors*

  2011cited by this paper
• Critical Role of Astroglial Apolipoprotein E and Liver X Receptor-α Expression for Microglial Aβ Phagocytosis

  2011cited by this paper
• Cross-Talk between Apolipoprotein E and Cytokines

  2011cited by this paper
• Linking lipids to Alzheimer's disease: cholesterol and beyond

  2011cited by this paper
• Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype

  2011cited by this paper
• Plasma apolipoprotein E and Alzheimer disease risk

  2011cited by this paper
• Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer’s disease and apoE TR mouse cortex

  2011cited by this paper
• C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-β (Aβ) and acts in concert with Aβ to elicit neuronal and behavioral deficits in mice

  2011cited by this paper
• Small Molecule Structure Correctors Abolish Detrimental Effects of Apolipoprotein E4 in Cultured Neurons*

  2011cited by this paper
• Apolipoprotein E: from lipid transport to neurobiology.

  2011influential reference
• Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

  2011cited by this paper
• ω-3 fatty acids and cognitive decline: modulation by ApoEε4 allele and depression.

  2011cited by this paper
• Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease.

  2011cited by this paper
• Mapping ApoE/Aβ binding regions to guide inhibitor discovery.

  2011cited by this paper
• Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions

  2011influential reference
• Apolipoprotein E Regulates the Integrity of Tight Junctions in an Isoform-dependent Manner in an in Vitro Blood-Brain Barrier Model*

  2011cited by this paper
• The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease

  2011cited by this paper
• Apolipoprotein E Promotes β-Amyloid Trafficking and Degradation by Modulating Microglial Cholesterol Levels*

  2011cited by this paper
• Presymptomatic apolipoprotein E genotyping for Alzheimer's disease risk assessment and prevention

  2011cited by this paper
• ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice*

  2010cited by this paper
• Apolipoprotein E4 Domain Interaction Mediates Detrimental Effects on Mitochondria and Is a Potential Therapeutic Target for Alzheimer Disease*

  2010influential reference
• Reduced Posterior Cingulate Mitochondrial Activity in Expired Young Adult Carriers of the APOE ε4 Allele, the Major Late-Onset Alzheimer's Susceptibility Gene

  2010cited by this paper
• Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.

  2010cited by this paper
• ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling

  2010cited by this paper
• APOE4 Allele Disrupts Resting State fMRI Connectivity in the Absence of Amyloid Plaques or Decreased CSF Aβ42

  2010cited by this paper
• APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging

  2010cited by this paper
• Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

  2010cited by this paper
• Differential Effects of ApoE Isoforms on Dendritic Spines In Vivo: Linking an Alzheimer's Disease Risk Factor with Synaptic Alterations

  2010cited by this paper
• Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2.

  2010cited by this paper
• ApoE mimetic peptide decreases Aβ production in vitro and in vivo

  2010cited by this paper
• Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice

  2010cited by this paper
• Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease

  2010cited by this paper
• Accumulation of intraneuronal Aβ correlates with ApoE4 genotype

  2010cited by this paper
• Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

  2009cited by this paper
• APOE genotype-specific differences in the innate immune response.

  2009cited by this paper

• Genetic and Hormonal Contributions to Psychosis Symptoms in Alzheimer’s Disease: A Sex-Stratified Analysis

  2026cites this paper
• Association of apolipoprotein E variants on Alzheimer's disease in Latin America: A systematic review and meta‐analysis

  2026cites this paper
• Examining APOE ε4 and Longitudinal Vascular Brain Injury: The Strong Heart Study.

  2026cites this paper
• Predictive Biomarkers for Asymptomatic Adults: Opportunities, Risks, and Guidance for General Practice

  2026cites this paper
• Unlocking the Genetic Code: A Systematic Review and Bioinformatic Analysis of the MS4A Gene Cluster’s Role in Alzheimer’s Disease

  2026cites this paper
• Correlation of peripheral olfactomedin 1 with Alzheimer’s disease and cognitive functions

  2025cites this paper
• Functional and effective EEG connectivity patterns in Alzheimer’s disease and mild cognitive impairment: a systematic review

  2025cites this paper
• Defining the contributions of tau pathology in the amygdala to increasing depressive symptoms in aging

  2025cites this paper
• Adipocyte metabolic state regulates glial phagocytic function

  2025cites this paper
• Significance of gene therapy in neurodegenerative diseases

  2025cites this paper
• Genetics and Epigenetics of Alzheimer’s Disease: Understanding Pathogenesis and Exploring Therapeutic Potential

  2025cites this paper
• Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets

  2025cites this paper
• Associations and interactions between premorbid cognitive health, apolipoprotein e4 genotype, and incident Alzheimer’s disease in UK Biobank (N = 252,340)

  2025cites this paper
• ApoE-calypse tau: ApoE-tau synergy in Alzheimer's disease.

  2025cites this paper
• Clinical Significance of APOE4 Genotyping: Potential for Personalized Therapy and Early Diagnosis of Alzheimer’s Disease

  2025cites this paper
• Exploring human brain development and disease using assembloids.

  2025cites this paper
• Disrupted theta oscillation propagation in healthy elderly individuals with apolipoprotein E epsilon 4 allele

  2025influential citation
• Glial Cells in Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Frontiers

  2025cites this paper
• Causal cardiovascular risk factors for dementia: insights from observational and genetic studies

  2024cites this paper
• Thyroid Hormone and Alzheimer's: Bridging Epidemiology to Mechanism.

  2024cites this paper
• Novel Gene Therapy Approaches for Targeting Neurodegenerative Disorders: Focusing on Delivering Neurotrophic Genes

  2024cites this paper
• Diabetes mellitus and risk of incident dementia in APOE ɛ4 carriers: an updated meta-analysis

  2024cites this paper
• Ethical Issues Around Treatment-Induced Amyloid-Related Imaging Abnormalities in Alzheimer's Disease

  2024cites this paper
• Temporal Characterization of the Amyloidogenic APPswe/PS1dE9;hAPOE4 Mouse Model of Alzheimer’s Disease

  2024cites this paper
• Silencing Apoe with divalent‐siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease

  2024cites this paper
• The Effectiveness of Centella asiatica Extract and Aerobic Exercise on Plasma Levels of Amyloid Beta-42 and Phosphorylated Tau in Older Women with Dementia

  2024cites this paper
• SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF Resulting in Drastic Soluble Protein Depletion

  2024cites this paper
• Long-term effects of APOEε4 on mortality.

  2024cites this paper
• Gut microbiota–astrocyte axis: new insights into age-related cognitive decline

  2024cites this paper
• Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches

  2024cites this paper
• Early onset diagnosis in Alzheimer’s disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluid

  2024cites this paper
• PEARL-Neuro Database: EEG, fMRI, health and lifestyle data of middle-aged people at risk of dementia

  2024cites this paper
• Molecular Mechanisms Linking Osteoarthritis and Alzheimer’s Disease: Shared Pathways, Mechanisms and Breakthrough Prospects

  2024cites this paper
• A philosophy of science approach to the amyloid hypothesis of Alzheimer's disease

  2024cites this paper
• Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies.

  2024cites this paper
• Integrating multi-omics data to reveal the effect of genetic variant rs6430538 on Alzheimer's disease risk

  2024cites this paper
• Functional network centrality indicates interactions between APOE4 and age across the clinical spectrum of AD

  2024cites this paper
• Sex and APOE Genotype Alter the Basal and Induced Inflammatory States of Primary Astrocytes from Humanized Targeted Replacement Mice

  2023cites this paper
• APOE ε4's impact on response to amyloid therapies in early symptomatic Alzheimer's disease: Analyses from multiple clinical trials

  2023cites this paper
• Release of frustration drives corneal amyloid disaggregation by brain chaperone

  2023cites this paper
• Two Routes to Alzheimer’s Disease Based on Differential Structural Changes in Key Brain Regions

  2023cites this paper
• scDiffCom: a tool for differential analysis of cell–cell interactions provides a mouse atlas of aging changes in intercellular communication

  2023cites this paper
• Inflammatory Blood Biomarkers Are Associated with Long-Term Clinical Disease Severity in Parkinson’s Disease

  2023cites this paper
• Flavonoids and fibrate modulate apoE4-induced processing of amyloid precursor protein in neuroblastoma cells

  2023cites this paper
• Apolipoprotein-E deficiency leads to brain network alteration characterized by diffusion MRI and graph theory

  2023cites this paper
• Apolipoprotein-E4: risk of severe malaria and mortality and cognitive impairment in pediatric cerebral malaria

  2023cites this paper
• GSK‐3β activation mediates apolipoprotein E4‐associated cognitive impairment in type 2 diabetes mellitus: A multicenter, cross‐sectional study

  2023cites this paper
• Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses

  2023cites this paper
• Differential and substrate-specific inhibition of γ-secretase by the C-terminal region of ApoE2, ApoE3, and ApoE4.

  2023cites this paper
• Identification of potential biomarkers related to mesenchymal stem cell response in patients with Alzheimer’s disease

  2023cites this paper
• Gene Expression Profiling as a Novel Diagnostic Tool for Neurodegenerative Disorders

  2023cites this paper
• Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders

  2023cites this paper
• Dilemma of Glial in Alzheimer’s: A Review of the Role of Glial Cells in Alzheimer’s Disease

  2023cites this paper
• Exploring the Impact of Coronavirus Disease 2019 on Dementia: A Review

  2023cites this paper
• Effects of APOE ε 4 genotype on age-associated change in cognitive functions among Japanese middle-aged and older adults: A 20-year follow-up study

  2022cites this paper
• The role of transforming growth factor β1 /Smad pathway in Alzheimer’s disease inflammation pathology

  2022cites this paper
• Uncovering mechanisms of brain inflammation in Alzheimer's disease with APOE4: Application of single cell‐type lipidomics

  2022cites this paper
• Alzheimer’s disease related single nucleotide polymorphisms and correlation with intracerebral hemorrhage incidence

  2022cites this paper
• A Haptoglobin (HP) Structural Variant Alters the Effect of APOE Alleles on Alzheimer’s Disease

  2022cites this paper
• Mercury Ion Binding to Apolipoprotein E Variants ApoE2, ApoE3, and ApoE4: Similar Binding Affinities but Different Structure Induction Effects

  2022cites this paper
• Proteomics reveals the key molecules involved in curcumin-induced protection against sciatic nerve injury in rats.

  2022cites this paper
• iPSCs in Neurodegenerative Disorders: A Unique Platform for Clinical Research and Personalized Medicine

  2022cites this paper
• Silencing of ApoE with Divalent siRNAs Drives Activation of Immune Clearance Pathways and Improves Amyloid Pathology in Mouse Models of Alzheimer’s Disease

  2022cites this paper
• Astrocytic Calcium and cAMP in Neurodegenerative Diseases

  2022cites this paper
• Distant Metastasis Pattern and Prognostic Prediction Model of Colorectal Cancer Patients Based on Big Data Mining

  2022cites this paper
• Aducanumab: Appropriate Use Recommendations Update

  2022cites this paper
• A review ofimaging genetics in Alzheimer's disease.

  2022cites this paper
• APOE genotype, hippocampus, and cognitive markers of Alzheimer's disease in American Indians: Data from the Strong Heart Study

  2022cites this paper
• Longitudinal analysis of the retina and choroid in cognitively normal individuals at higher genetic risk for Alzheimer disease.

  2022cites this paper
• Genetic Regulatory Networks of Apolipoproteins and Associated Medical Risks

  2022cites this paper
• Human apolipoprotein E isoforms are differentially sialylated and the sialic acid moiety in ApoE2 attenuates ApoE2-Aβ interaction and Aβ fibrillation.

  2022cites this paper
• Bioinformatics Analysis of Publicly Available Single-Nuclei Transcriptomics Alzheimer’s Disease Datasets Reveals APOE Genotype-Specific Changes Across Cell Types in Two Brain Regions

  2022influential citation
• Kynurenine Pathway Metabolites as Biomarkers in Alzheimer's Disease

  2022cites this paper
• Predicting Alzheimer's disease with practice effects, APOE genotype and brain metabolism.

  2022cites this paper
• Evaluation of mild cognitive impairment genetic susceptibility risks in a Chinese population

  2022cites this paper
• Effects of APOE ε 4 genotype on age-associated change in cognitive functions among Japanese middle-aged and older adults: A 20-year follow-up study

  2022cites this paper
• Endogenous Human Proteins Interfering with Amyloid Formation

  2022influential citation
• Age-dependent impact of early-life stress on glia and synapses Substrates for increased risk for Alzheimer’s disease

  2022cites this paper
• Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease

  2022cites this paper
• Effect of physical exercise on cognitive function in older adults’ carriers versus noncarriers of apolipoprotein E4: systematic review and meta-analysis

  2021influential citation
• APOE4 Regulates Synaptic Function by Directly Modulating the SNARE Complex Assembly

  2021cites this paper
• Single-cell transcriptomic analysis elucidates APOE genotype specific changes across cell types in two brain regions in Alzheimer’s disease

  2021cites this paper
• Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study

  2021cites this paper
• The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers

  2021cites this paper
• Gender Comparison Of Apolipoprotein And Lipid Profiles In Hiv Seropositives In Nauth Nnewi, South Eastern Nigeria

  2021cites this paper
• Associations Between Neighborhood Park Access and Longitudinal Change in Cognition in Older Adults: The Multi-Ethnic Study of Atherosclerosis

  2021cites this paper
• Current Pharmaceutical Biotechnology

  2021cites this paper
• Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage

  2021cites this paper
• APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics

  2021cites this paper
• Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer's disease.

  2021cites this paper
• The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer’s Disease: Exploring Interactions With Sex

  2021cites this paper
• Cognitive decline in amyotrophic lateral sclerosis: Neuropathological substrate and genetic determinants

  2021cites this paper
• An evidence-based review of neuronal cholesterol role in dementia and statins as a pharmacotherapy in reducing risk of dementia

  2021cites this paper
• Anaemia and cerebrospinal fluid biomarkers of Alzheimer’s pathology in cognitively normal elders: the CABLE study

  2021cites this paper
• Gene-based therapies for neurodegenerative diseases

  2021cites this paper
• Culture Variabilities of Human iPSC-Derived Cerebral Organoids Are a Major Issue for the Modelling of Phenotypes Observed in Alzheimer’s Disease

  2021cites this paper
• The impact of genetic risk for Alzheimer’s disease on the structural brain networks of young adults

  2021cites this paper
• Association of ApoE Genotypes and Recovery From Intracerebral Hemorrhage in Very Low Birth Weight Infants

  2021cites this paper
• Principles of brain aging: Status and challenges of modeling human molecular changes in mice.

  2021cites this paper
• Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer's pathology: Insights and therapeutic approaches from periphery.

  2021influential citation